The Ministry of Health (Minsa) of Panama announced that the Directorate of Pharmacies and Drugs has already begun the process of reviewing the portfolio of the Chinese Sinovac vaccine against covid-19.
The entity indicated that it is the
vaccine with series 004-DNFD and once the review process is concluded it would be the fourth
vaccine with authorization for emergency use in the country.
This week, Farmacias y Drogas authorized the emergency use of the Russian
vaccine Sputnik V, after concluding with the reviews of the dossier.
Currently in the country the preparation of the American pharmaceutical company
Pfizer is being applied, with which 450 thousand doses were agreed for the first quarter of this year.
It was also confirmed that Panama will receive some 216 thousand doses of the
AstraZeneca covid-19
vaccine, through the
Covax mechanism promoted by the World Health Organization (WHO).
Regarding the reports of a possible relationship between this formula with cases of thrombosis, the Minister of Health, Luis
Sucre said that the reports of international health organizations have ruled this out and no one will be forced to apply it.